Search Results - "Forest, Stefanie"

Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer by Shapiro, Lauren C., Thakkar, Astha, Campbell, Sean T., Forest, Stefanie K., Pradhan, Kith, Gonzalez-Lugo, Jesus D., Quinn, Ryann, Bhagat, Tushar D., Choudhary, Gaurav S., McCort, Margaret, Sica, R. Alejandro, Goldfinger, Mendel, Goel, Swati, Anampa, Jesus D., Levitz, David, Fromowitz, Ariel, Shah, Akash Pradip, Sklow, Charlotte, Alfieri, Gregory, Racine, Andrew, Wolgast, Lucia, Greenberger, Lee, Verma, Amit, Halmos, Balazs

“…Anti-COVID-19 immunity dynamics were assessed in patients with cancer in a prospective clinical trial. Waning of immunity was detected 4-6 months…”
Get full text

Management of the Platelet Refractory Patient by Forest, Stefanie K., MD, PhD, Hod, Eldad A., MD

“…Platelet refractoriness occurs when there is an inadequate response to platelet transfusions, which typically has nonimmune causes, but is also associated with…”
Get full text

Cardiothoracic operating room blood gas workflow performance improvement initiative by Forest, Stefanie K, Kuan, Kevin, Edema, Ukuemi, Forest, Stephen J, Leff, Jonathan D

“…Abstract Objectives To evaluate the current workflow of blood gas ordering and testing in a cardiothoracic operating room to identify opportunities to…”
Get full text

Equity and Performance Improvement: A Novel Toolkit That Makes Using an Equity Lens the Default by Ganz-Lord, Fran A, Beechner, Paul, Wnorowksi, Mark, Asante, Dennis, Johnson, Kenay, Bianco, John, Gazivoda, Susan, Forest, Stefanie K

“…Performance improvement methodologies do not currently include any structures that encourage analysis of how bias, inequity, or social determinants of health…”
Get full text

De Novo Renal Failure and Clinical Outcomes of Patients With Critical Coronavirus Disease 2019 by Forest, Stephen J., Michler, Robert E., Skendelas, John P., DeRose, Joseph J., Friedmann, Patricia, Parides, Michael K., Forest, Stefanie K., Chauhan, Dhaval, Goldstein, Daniel J.

“…OBJECTIVES:To describe the characteristics and outcomes associated with concomitant renal and respiratory failure in patients with critical coronavirus disease…”
Get full text

Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients by Cowman, Kelsie, Rossi, James, Gendlina, Inessa, Guo, Yi, Liu, Sichen, Szymczak, Wendy, Forest, Stefanie K., Wolgast, Lucia, Orner, Erika, Bao, Hongkai, Cervera-Hernandez, Miguel E., Ceniceros, Ashley, Thota, Raja, Pirofski, Liise-anne, Nori, Priya

“…•There is excess antibiotic use in hospitalized COVID-19 patients despite low prevalence of bacterial co-infection.•Procalcitonin has a high NPV but low PPV…”
Get full text

Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models by Acker, Christopher M, Forest, Stefanie K, Zinkowski, Ray, Davies, Peter, d'Abramo, Cristina

“…Abstract Transgenic mouse models have been an invaluable resource in elucidating the complex roles of β-amyloid and tau in Alzheimer's disease. Although many…”
Get full text

The Impact of an Electronic Ordering System on Blood Bank Specimen Rejection Rates by Forest, Stefanie K., Shirazi, Maryam, Wu-Gall, Charlotte, Stotler, Brie A.

“…Objectives: To evaluate the impact that an electronic ordering system has on the rate of rejection of blood type and screen testing samples and the impact on…”
Get full text

Detecting tau in serum of transgenic animal models after tau immunotherapy treatment by d'Abramo, Cristina, Acker, Christopher M, Schachter, Joel B, Terracina, Giuseppe, Wang, Xiaohai, Forest, Stefanie K, Davies, Peter

“…Abstract In the attempt to elucidate if the “peripheral sink hypothesis” could be a potential mechanism of action for tau removal in passive immunotherapy…”
Get full text

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays: The Value of Numeric Reporting by Forest, Stefanie K, Orner, Erika P, Goldstein, D. Yitzchak, Wirchnianski, Ariel S, Bortz, Robert H., III, Laudermilch, Ethan, Florez, Catalina, Malonis, Ryan J, Georgiev, George I, Vergnolle, Olivia, Lo, Yungtai, Campbell, Sean T, Barnhill, Jason, Cadoff, Evan M, Lai, Jonathan R, Chandran, Kartik, Weiss, Louis M, Fox, Amy S, Prystowsky, Michael B, Wolgast, Lucia R

“…Context.— Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) testing is used for serosurveillance and will be important to…”
Get full text

Methods for measuring tau pathology in transgenic mouse models by Forest, Stefanie K, Acker, Christopher M, d'Abramo, Cristina, Davies, Peter

“…In Alzheimer's disease (AD) and tauopathies, tau becomes hyperphosphorylated, undergoes a conformational change, and becomes aggregated and insoluble. There…”
Get more information

Automated Laboratories: When Technology Needs a Human Touch by Forest, Stefanie K, Vossoughi, Sarah R, Connelly, Charles, Stotler, Brie A

Get full text

Critical Value Reporting Performance Improvement Initiative: A Journey Towards Timely Patient Safety by Kuan, Kevin, Forest, Stefanie

“…Abstract Timely reporting of critical values serves as a quality indicator for the National Patient Safety Goal. Since the oncology inpatient unit at our…”
Get full text

Covid-19 and Kidney Transplantation by Akalin, Enver, Azzi, Yorg, Bartash, Rachel, Seethamraju, Harish, Parides, Michael, Hemmige, Vagish, Ross, Michael, Forest, Stefanie, Goldstein, Yitz D, Ajaimy, Maria, Liriano-Ward, Luz, Pynadath, Cindy, Loarte-Campos, Pablo, Nandigam, Purna B, Graham, Jay, Le, Marie, Rocca, Juan, Kinkhabwala, Milan

“…A cohort of 36 consecutive kidney-transplant recipients had less fever, lower CD3, CD4, and CD8 cell counts, more rapid clinical deterioration, and a higher…”
Get full text

COVID-19 infection in kidney transplant recipients at the epicenter of pandemics by Azzi, Yorg, Parides, Michael, Alani, Omar, Loarte-Campos, Pablo, Bartash, Rachel, Forest, Stefanie, Colovai, Adriana, Ajaimy, Maria, Liriano-Ward, Luz, Pynadath, Cindy, Graham, Jay, Le, Marie, Greenstein, Stuart, Rocca, Juan, Kinkhabwala, Milan, Akalin, Enver

“…We investigated the prevalence and clinical outcomes of COVID-19 in recipients of kidney transplants in the Bronx, New York, one of the epicenters of the…”
Get more information

To Repeat or Not to Repeat: An Evaluation of Critical Values in Chemistry Laboratory Testing by Balakrishnan, Ridin, Forest, Stefanie

“…Abstract It is common laboratory practice to repeat critical values before reporting the result. However, the benefits of repeat testing are unclear. There are…”
Get full text

The Burden of Add-On Orders in a Laboratory With Manual Processing by Barouqa, Mohammad, Fecher, Roger, Wolgast, Lucia R, Forest, Stefanie

“…Abstract In order to avoid additional blood draws for their patients, clinicians frequently order add-on tests on existing specimens in the laboratory…”
Get full text

75 A Proactive Risk Assessment of Electronic Blood Product Ordering by Forest, Stefanie, Vossoughi, Sarah, Parker-Jones, Sylvia, Evangelista, Michelle, Nachamie, Anna, Schwartz, Joseph

“…Abstract Transfusion of blood components is a complex multidisciplinary process from provider order, to blood bank processing, to administration. Errors at any…”
Get full text

37 Automated Laboratories: When Technology Needs a Human Touch by Forest, Stefanie, Vossoughi, Sarah, Connelly, Charles, Kratz, Alexander, Stotler, Brie

“…Abstract The technological revolution has changed the field of laboratory medicine with a shift from manual specimen processing to automation. Many…”
Get full text

8 Performance improvement in laboratory medicine: a critical value reporting improvement initiative by Forest, Stefanie, Beechner, Paul, Johnson, Kenay, Ganz-Lord, Fran

“…BackgroundTimely reporting of critical values is a National Patient Safety Goal. Critical values are reported by telephone call from pathology customer service…”
Get full text